Parkinson's disease is best known for the tremors and movement difficulties that emerge as it progresses, but the earliest biological changes may start much earlier — and possibly in a completely different part of the body. A team of researchers from Aarhus University and Tel Aviv University has received a major European Union grant to investigate whether the disease could, in some cases, begin in the skin.

Professor Per Borghammer and Associate Professor Nathalie Van Den Berge from Aarhus University's Department of Clinical Medicine, together with Professor Avraham Ashkenazi from Tel Aviv University, will explore whether environmental toxicants such as pesticides and industrial solvents can trigger disease-related changes in nerve endings in the skin, according to Aarhus University's announcement. The project, named DERMIS-PD, has received an ERC Synergy Grant of DKK 80 million (approximately €10.7 million) from the European Research Council, with just over DKK 52 million allocated to Aarhus University.

"Parkinson's disease begins many years before the first movement symptoms appear. By understanding how environmental exposures interact with the vulnerability of specific nerve cells, we hope to uncover the earliest mechanisms of the disease and open new possibilities for early detection and prevention," the researchers said in the announcement.

To test their hypothesis, the team will combine animal models, studies of patients, and research on nerve cells derived from human stem cells. The goal is to better understand how the disease starts and what role environmental exposures may play in that process.

For university students studying medicine, neuroscience, or environmental health, this research highlights a growing area of investigation into how external factors may influence neurological disease long before symptoms appear. It also underscores the value of interdisciplinary collaboration — the project brings together expertise in neurology, toxicology, and stem cell biology across two continents.

The ERC Synergy Grant is one of the European Union's most prestigious research awards, designed to support ambitious projects that require collaboration between multiple research groups. The grant will fund the project over several years, though the announcement did not specify the exact duration.

If the team's hypothesis is confirmed, it could shift the understanding of Parkinson's disease from a brain-centred disorder to one that may originate in peripheral tissues, potentially opening new avenues for early screening and preventive strategies. However, the research is at an early stage, and the findings from animal and cell models will need to be validated in human studies before any clinical applications can be considered.